Laboratory techniques

Delta Variant? There Are Others. Milford Molecular Diagnostics Laboratory Routinely Diagnoses Variants of SARS-CoV-2, Including Alpha, Beta, Gamma, Delta, Epsilon, Eta, Iota, Kappa and Lambda Variants

Thursday, July 29, 2021 - 7:17pm

Sin Hang Lee, director of Milford Molecular Diagnostics, summarizing recently published sequence-based surveillance data.

Key Points: 
  • Sin Hang Lee, director of Milford Molecular Diagnostics, summarizing recently published sequence-based surveillance data.
  • View the full release here: https://www.businesswire.com/news/home/20210729006029/en/
    However, he added, there exists no known diagnostic method for these variants in the U.S. for individual patient samples outside of Milford Diagnostics Laboratory.
  • All variants of concern or of interest must have at least one of these 8 mutated amino acids.
  • Milford Molecular Diagnostics Laboratory is CLIA-certified to perform nested RT-PCR/DNA sequencing for diagnosis of SARS-Co-V-2 and reflex spike protein gene sequencing for variant determination.

A.Menarini Diagnostics launches a new Real Time PCR kit for SARS CoV-2 detection and variant screening, CE marked.

Thursday, July 29, 2021 - 7:40pm

FLORENCE, Italy, July 29, 2021 /PRNewswire/ -- Menarini Diagnostics, part of the Menarini Group, announced today the release of a new version of the CoronaMelt Kit launched in November 2020.

Key Points: 
  • FLORENCE, Italy, July 29, 2021 /PRNewswire/ -- Menarini Diagnostics, part of the Menarini Group, announced today the release of a new version of the CoronaMelt Kit launched in November 2020.
  • The second-generation kit, CoronaMelt VAR, will combine SARS CoV-2 viral detection with concurrent genotyping of Alpha, Beta and Gamma variants (formerly known as UK, South African and Brazilian) in an IVD certified diagnostic format validated for use on laboratory Real Time PCR instruments.
  • CoronaMelt VAR is validated for use from oro/nasopharyngeal swabs with the use of standard magnetic bead or column RNA purification solution.
  • The kit is also included in the portfolio of assays that can be fully automated on the Omnia liquid handling series.

Stilla Launches Access Program for Industry’s First Six-Color Digital PCR System

Wednesday, July 28, 2021 - 5:26pm

Stilla Technologies , the company innovating the next generation of digital PCR solutions for life science research and molecular diagnostics, is pleased to announce the launch of its 6-Color Digital PCR Access Program which enables early access to the industrys first Digital PCR system featuring six fluorescent channels for providing the highest multiplexing and detection capacity available on the market today.

Key Points: 
  • Stilla Technologies , the company innovating the next generation of digital PCR solutions for life science research and molecular diagnostics, is pleased to announce the launch of its 6-Color Digital PCR Access Program which enables early access to the industrys first Digital PCR system featuring six fluorescent channels for providing the highest multiplexing and detection capacity available on the market today.
  • This represents a broad portfolio expansion of the Companys original three-color naica system and includes reagents and digital PCR consumables, automated analytical instrumentation, and turnkey visualization software.
  • Stilla is offering scientists an opportunity to experience the power and flexibility of 6-color Digital PCR by providing a range of options to drive their evaluations, including both hands-on or remote demonstrations of the naica system.
  • For more information on the Crystal Digital PCR Access Program, email demo@stillatechnologies.com or sign up online at: https://www.stillatechnologies.com/6-color-dpcr/ .

Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market Report 2021-2025: Market is Poised to Grow by $265.55 Million - Increase in Chronic Diseases Driving Market Growth - ResearchAndMarkets.com

Wednesday, July 28, 2021 - 1:49pm

The "Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Enzyme-linked Immunosorbent Assay (Elisa) Testing Market 2021-2025" report has been added to ResearchAndMarkets.com's offering.
  • The report on the enzyme-linked immunosorbent assay (Elisa) testing market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
  • The enzyme-linked immunosorbent assay (Elisa) testing market analysis includes the end-user segment and geographic landscape.
  • This study identifies the increase in chronic diseases as one of the prime reasons driving the enzyme-linked immunosorbent assay (Elisa) testing market growth during the next few years.

PerkinElmer Expands KRAS Oncology Drug Discovery Assays with New Ready-to-Use AlphaLISA Kits

Wednesday, July 28, 2021 - 1:00pm

Researchers will now be able to choose between PerkinElmers HTRF or AlphaLISA assays to use the best methods for their individual labs.

Key Points: 
  • Researchers will now be able to choose between PerkinElmers HTRF or AlphaLISA assays to use the best methods for their individual labs.
  • The Companys AlphaLISA and HTRF kits are the first ready-to-use homogenous assays for KRAS/SOS1 inhibition analysis on the market.
  • PerkinElmers AlphaLISA and HTRF kits streamline workflows by offering fully validated kits to identify novel KRAS inhibitors in a no-wash format with no optimization necessary, and each kit comes with recombinant proteins, detection reagents, and assay buffers.
  • Because KRAS mutations are found in numerous types of cancer, from lung to colorectal to pancreatic cancers, its a prime drug target.

Industry Leading Piezo Objective Scanners for fast AutoFocus and Metrology Applications with Nanometer Precision

Wednesday, July 28, 2021 - 5:40pm

Available in 3 travel ranges of 100m, 400m, and an industry leading 800m, high performance fast focusing with nanometer precision is achieved for applications such as super resolution microscopy, genome sequencing, wafer metrology, digital pathology, and laser material processing.

Key Points: 
  • Available in 3 travel ranges of 100m, 400m, and an industry leading 800m, high performance fast focusing with nanometer precision is achieved for applications such as super resolution microscopy, genome sequencing, wafer metrology, digital pathology, and laser material processing.
  • Equipped with direct measuring sensors for the highest linearity and stability, the frictionless piezo drive ensures rapid response, high stiffness, and a fast settling time of a few milliseconds.
  • Piezo-flexure guided focusing stages are more compact, provide better straightness, flatness, and reduced angular errors, commonly known as guiding precision.
  • PI's customers are leaders in high-tech industries and research institutes in fields such as photonics, life-sciences, semiconductors, and aerospace.

5 Reasons Why The Next Gold Rush Will Happen In Canada

Wednesday, July 28, 2021 - 1:00pm

During historical production, the main focus was on copper, while gold was treated as a secondary product.

Key Points: 
  • During historical production, the main focus was on copper, while gold was treated as a secondary product.
  • Additionally, high-resolution drone mag surveying covering the entire property was conducted to define gold structures and help identify drill targets.
  • In December last year, Starr Peak received high-grade gold results from grab samples taken on a field visit carried out in September 2020.
  • Highlight assay results sampled on Turgeon Lakeshoreline returned 157, 31.8 and 9.77 g/t Au, confirming the historical grab samples at Turgeon Lake gold showing.

5 Reasons Why The Next Gold Rush Will Happen In Canada

Wednesday, July 28, 2021 - 1:00pm

LONDON, July 28, 2021 /PRNewswire/ -- A new gold exploration in Quebec may be starting to ping radar because it keeps on hitting new mineralization and reports say it's gone beyond gold. Mentioned in today's commentary includes: Sociedad Química y Minera de Chile S.A. (NYSE: SQM), Freeport-McMoRan Inc. (NYSE: FCX), Gold Fields Limited (NYSE: GFI), Compañía de Minas Buenaventura S.A.A. (NYSE: BVN), Harmony Gold Mining Company Limited (NYSE: HMY).

Key Points: 
  • During historical production, the main focus was on copper, while gold was treated as a secondary product.
  • Additionally, high-resolution drone mag surveying covering the entire property was conducted to define gold structures and help identify drill targets.
  • In December last year, Starr Peak received high-grade gold results from grab samples taken on a field visit carried out in September 2020.
  • Highlight assay results sampled on Turgeon Lakeshoreline returned 157, 31.8 and 9.77 g/t Au, confirming the historical grab samples at Turgeon Lake gold showing.

Bio-Techne and PROGEN Introduce New Simple Plex AAV2 Immunoassay

Wednesday, July 28, 2021 - 12:00pm

Bio-Techne, owner of the leading ProteinSimple branded protein analysis portfolio of products, and PROGEN will offer the Simple Plex AAV2 viral titer assay on Ella instruments, its multiplexing immunoassay system.

Key Points: 
  • Bio-Techne, owner of the leading ProteinSimple branded protein analysis portfolio of products, and PROGEN will offer the Simple Plex AAV2 viral titer assay on Ella instruments, its multiplexing immunoassay system.
  • Featuring antibodies from PROGEN, the Simple Plex AAV2 viral titer assay detects assembled viral capsids as well as the comprehensively characterized AAV2 standard to deliver industry leading specificity.
  • Available on the Ella platform, the Simple Plex AAV2 assay utilizes the recombinant AAV2 antibody (A20R) from industry leader PROGEN to quantify assembled AAV2 capsids.
  • "Working with ProteinSimple to develop the Simple Plex AAV2 assay was a great experience," said Katja Betts, CEO of PROGEN.

Crossing Blood-Brain Barrier: Delivery of Biomolecules into Glioblastoma Enabled by Altogen's Nanoparticle In Vivo Transfection Reagent

Tuesday, July 27, 2021 - 8:43pm

In 2018 Altogen Biosystems launched the AltoFect transfection reagent formulated for difficult-to-transfect cells (like B-cells, T-cells), and primary cell cultures that are known to be resistant to most typical transfection technologies.

Key Points: 
  • In 2018 Altogen Biosystems launched the AltoFect transfection reagent formulated for difficult-to-transfect cells (like B-cells, T-cells), and primary cell cultures that are known to be resistant to most typical transfection technologies.
  • Company offers over 120 cell-line specific transfection kits, optimized electroporation products, and in vivo transfection reagents that are used for tissue-targeted delivery of negatively charged biomolecules (siRNA/miRNA, mRNA, plasmid DNA, small proteins, etc).
  • Altogen Biosystems announced that its Nanoparticle-basedIn VivoTransfection Reagent was used for effective overcoming blood-brain barrier and successful transfection of glioblastoma tumor cells with both plasmid DNA and siRNA molecules.
  • Altogen's nanoparticle in vivo transfection reagent was referenced in over 40 research publications for effective in vivo delivery of biomolecules, however Altogen scientists still had to develop modified in vivo transfection protocol to enable brain-targeted delivery.